Novavax Medical Information

DISCLAIMER: THIS PAGE IS INTENDED FOR HEALTHCARE PROFESSIONALS AND OTHER RELEVANT DECISION MAKERS IN Luxembourg ONLY.

If you are NOT a Healthcare Professional in Luxembourg, please switch to the Consumer Medical Information page.

If you are a Healthcare Professional in another country, please go back to country selection.

Information on the NuvaxovidTM XBB.1.5 dispersion for injection COVID-19 Vaccine (recombinant, adjuvanted) (NVX-CoV2601)

If your enquiry is regarding the NuvaxovidTM XBB.1.5 dispersion for injection COVID-19 Vaccine (recombinant, adjuvanted) (NVX-CoV2601), you can find some useful information in the resources below.

Request Medical Information

Do you have a medical or scientific question about a Novavax medicinal product? Get in touch with Novavax Medical Information experts who will provide tailored, evidence-based, balanced, and up-to-date medical information. 

Healthcare Professionals may request medical information via ONE of the following ways:

Option 1: Complete and submit a Medical Information Request Form by clicking on the button below.

Request Medical Information

Option 2: Call +352 20 33 17 08 between 09:00-17:00.

Report an Adverse Event (AE)

If you are concerned about an adverse event, it should be reported to the Ministry of Health https://sante.public.lu.

Alternatively, adverse events of serious concern in association with a Novavax product can be reported to Novavax Pharmacovigilance at +352 20 33 17 08 or via the Novavax Adverse Event Reporting Form.

Report a Product Quality Complaint

If you have a product quality complaint related to a physical issue with a Novavax product or its packaging, please report the complaint via ONE of the following ways:

Option 1: Complete and submit a Product Quality Complaint Form by clicking on the button below.

Report a Product Quality Complaint

Option 2: Call +352 20 33 17 08 between 09:00-17:00.